C([O:8][C@@H:9]1[CH2:13][CH2:12][CH2:11][C@H:10]1[C:14]1[CH:18]=[CH:17][N:16]([CH:19]2[CH2:24][CH2:23][CH2:22][CH2:21][O:20]2)[N:15]=1)C1C=CC=CC=1>[C].[Pd].C(O)C>[O:20]1[CH2:21][CH2:22][CH2:23][CH2:24][CH:19]1[N:16]1[CH:17]=[CH:18][C:14]([C@@H:10]2[CH2:11][CH2:12][CH2:13][C@H:9]2[OH:8])=[N:15]1The reaction and aftertreatment were conducted in the same manner as in Example 106b by using the 3-[(1S,2R)-2-(benzyloxy)cyclopentyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol (419 mg, 1.28 mmol) prepared in Example 149b, palladium carbon (5%; 400 mg) and ethanol (20 mL), to yield the title compound (269 mg, 89%) in the form of a diastereomeric mixture as a colorless oil.
Loading…